The impact-intensive and rapidly growing pharmaceutical industry must ensure its sustainability. This study reveals that environmental sustainability assessments have been conducted for only around 0.2% of pharmaceuticals, environmental impacts have significant variations among the assessed products, and different impact categories have not been consistently studied. Highly varied impacts require assessing more products to understand the industry's sustainability status. Reporting all impact categories will be crucial, especially when comparing production technologies. Biological production of (semi)synthetic pharmaceuticals could reduce their environmental costs, though the high impacts of biologically produced monoclonal antibodies should also be optimized. Considering the sustainability potential of biopharmaceuticals from economic, environmental, and social perspectives, collaboratively guiding their immense market growth would lead to the industry's sustainability transition.
Microbial refactoring offers sustainable production of plant-sourced pharmaceuticals associated with high production costs, ecological harms, and supply chain dependencies. Here, microbial tabersonine production in Saccharomyces cerevisiae is modeled during early-stage development (TRL: 3-5), guiding decisions for process-scale economic and environmental optimization. The base-case 0.7 mg/L titer indicated a minimum selling price (MSP) of $3,910,000/kg and global warming potential (GWP) of 2,540 kgCO2eq/g. The industrial process at 1 g/L resulted in an MSP of 4,262 $/kg and a GWP of 6.36 kgCO2eq/g. Location analysis indicated a sustainability trade-off between France, USA, Poland, and China, with the written order of declining MSP and increasing GWP. Continuous processing promised reducing the MSP by 18-27 %, and the GWP by 17-31 %. In-situ product extraction during fermentation was estimated to lower the MSP by 41-61 %, and the GWP by 30-75 %. In addition to showcasing a combined TEA-LCA on biopharmaceuticals, the early-stage assessment approach guides bioprocess optimization.
This work demonstrates an additive and hydrogen‐free 2‐step lignin‐first fractionation in flow‐through. First, solvolytic delignification renders lignin liquors with its native chemical structure largely intact; and second, ß‐zeolite catalytic depolymerization of these liquors leads to similar monomer yields as the corresponding 1‐step fractionation process. Higher delignification temperatures lead to slightly lower ß−O−4 content in the solvated lignin, but does not affect significantly the monomer yield, so a higher temperature was overall preferred as it promotes faster delignification. Deposition of Pd on ß‐zeolite resulted in a bifunctional hydrogenation/dehydration catalyst, tested during the catalytic depolymerization of solvated lignin with and without hydrogen addition. Pd/ß‐zeolite displays synergistic effects (compared to the Pd/γ‐Al2O3 and ß‐zeolite tested individually and as a mixed bed), resulting in higher monomer yield. This is likely caused by increased acidity and the proximity between the metallic and acid active sites. Furthermore, different ß‐zeolite with varying SAR and textural properties were studied to shed light onto the effect of acidity and porosity in the stabilization of lignin monomers. While some of the catalysts showed stable performance, characterization of the spent catalyst reveals Al leaching (causing acidity loss and changes in textural properties), and some degree of coking and Pd sintering.
Solvents play a pivotal role in crystallisation, affecting crystal growth and properties. This study investigates the regeneration behaviour of paracetamol crystals in ethanol, tetrahydrofuran, and acetone using both evaporative and isothermal crystallisation setups, coupled with a custom MATLAB-based edge detection algorithm for facet-specific growth rate measurements. Regeneration was observed in all solvents, with the fastest rate observed in ethanol (0.07 mm h−1), followed by THF (0.03 mm h−1), and acetone (0.02 mm h−1) at a supersaturation ratio of 1.10. In all cases, regeneration was driven by rapid growth of the (0 1 0) facet, restoring crystals to their original shapes. Crystal shape influenced the regeneration time, with a rapid initial phase comprising 8–15% of total regeneration time. Molecular dynamics simulations were utilised to quantify solvent–crystal interactions, showing that not only do the inherent solvent properties play a role but also the solubility of paracetamol significantly affects crystal regeneration.